Back
PTC Therapeutics Stock Price Chart

Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
PTCT
PTC Therapeutics
Last Price:
$48.63
Seasonality Move:
-6%
7 Day Trial
ALL ACCESS PASS
$
7

BOXABL Announces New $20,000 House
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular here. This is a message from Boxabl-
The current trend is moderately bullish and PTCT is experiencing slight buying pressure.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.81 | Buy |
20-day SMA: | 46.25 | Buy |
50-day SMA: | 46.55 | Buy |
200-day SMA: | 38.27 | Buy |
8-day EMA: | 48.8 | Buy |
20-day EMA: | 47.29 | Buy |
50-day EMA: | 45.69 | Buy |
200-day EMA: | 39.67 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.24 | Buy |
Relative Strength Index (14 RSI): | 64 | Buy |
Chaikin Money Flow: | 269495 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.65 - 48.43) | Buy |
Bollinger Bands (100): | (38.56 - 47.4) | Buy |
PTC Therapeutics Technical Analysis
Jan 28 | Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 49.82 while PTCT 8-day simple moving average is 48.81, which is a Buy signal.
-
The stock price of PTCT is 49.82 while PTC Therapeutics 20-day SMA is 46.25, which makes it a Buy.
-
PTC Therapeutics 50-day simple moving average is 46.55 while PTCT share price is 49.82, making it a Buy technically.
-
PTCT stock price is 49.82 and PTC Therapeutics 200-day simple moving average is 38.27, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Sell
42
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a SellThe current PTC Therapeutics [PTCT] share price is $49.82. The Score for PTCT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
PTC Therapeutics Stock Info
Market Cap:
3.8B
Price in USD:
49.82
Share Volume:
854.4K
PTC Therapeutics 52-Week Range
52-Week High:
54.16
52-Week Low:
23.58
Sell
42
PTC Therapeutics (PTCT)
is a Sell
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?The PTC Therapeutics stock price is 49.82 USD today.
-
Will PTCT stock go up or go down?PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is PTC Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is overvalued.
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 49.82 while PTCT 8-day exponential moving average is 48.80, which is a Buy signal.
-
The stock price of PTCT is 49.82 while PTC Therapeutics 20-day EMA is 47.29, which makes it a Buy.
-
PTC Therapeutics 50-day exponential moving average is 45.69 while PTCT share price is 49.82, making it a Buy technically.
-
PTCT stock price is 49.82 and PTC Therapeutics 200-day simple moving average is 39.67, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $1.09 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
-
PTCT Moving Average Covergence Divergence (MACD) indicator is 1.24, suggesting PTC Therapeutics is a Buy
-
PTC Therapeutics Relative Strength Index (RSI) is 64, which suggest PTC Therapeutics is overbought
-
The Bollinger Bands (25) for PTC Therapeutics is (43.65 - 48.43), which suggest PTC Therapeutics is a Buy
-
The Bollinger Bands (100) for PTC Therapeutics is (38.56 - 47.4), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.